Study ID: C18083/2046 | 2010-020768-40
Study Title
- Study of Bendamustine Hydrochloride for the Treatment of Pediatric Patients With Relapsed or Refractory Acute Leukemia
Teva Identifier
- C18083/2046 | 2010-020768-40
ClinicalTrials.gov Identifier
- NCT01088984
Study Status
- Completed
Trial Condition(s)
- Leukemia
Interventions
- Drug: Bendamustine
Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
Gender
- Female, Male
Age Range
- 1 Year to 20 Years
Trial Duration
- 08/01/2010 - 08/01/2011
Phase
- Phase 1/2
Study Type
Interventional
